Long-term management and results in heart transplant recipients. 1990

H A Valantine
Division of Cardiology, Stanford University School of Medicine, California.

This article reviews the evolution of therapeutic strategies for maintenance immunosuppression, and presents current approaches to prevention, treatment, and surveillance of acute rejection. Other major complications influencing mortality and morbidity are discussed; these include infection, cyclosporine nephrotoxicity, malignancy, and bone disease.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D003524 Cyclosporins A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. Cyclosporines
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D001706 Biopsy Removal and pathologic examination of specimens from the living body. Biopsies
D016027 Heart Transplantation The transference of a heart from one human or animal to another. Cardiac Transplantation,Grafting, Heart,Transplantation, Cardiac,Transplantation, Heart,Cardiac Transplantations,Graftings, Heart,Heart Grafting,Heart Graftings,Heart Transplantations,Transplantations, Cardiac,Transplantations, Heart

Related Publications

H A Valantine
January 1991, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
H A Valantine
February 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
H A Valantine
April 2015, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation,
H A Valantine
January 2008, Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia,
H A Valantine
July 2016, Deutsche medizinische Wochenschrift (1946),
H A Valantine
March 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
H A Valantine
December 2007, Progress in transplantation (Aliso Viejo, Calif.),
H A Valantine
May 2011, Journal of Korean medical science,
H A Valantine
June 2017, Best practice & research. Clinical anaesthesiology,
Copied contents to your clipboard!